Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR       

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat autoimmune diseases.The company's primary product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF, which has been associated with a... 
Sector
Pharmaceuticals
Calendar
03/24Earnings Release
More about the company
Financials ($)
Sales 2014 -
EBIT 2014 -29,3 M
Net income 2014 -30,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -37,4 M
Net income 2015 -38,8 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 47,5 M
More Financials
Latest news on ANTA PHAR
01/18 Anthera Pharmaceuticals Appoints Klara Dickinson as SVP, Chief Regulatory Off..
01/13 Anthera Pharmaceuticals Names Klara Dickinson as SVP, Chief Regulatory Office..
01/08 ANTHERA PHARMACEUTICALS : Announces Lupus Symposium During 2015 JP Morgan Health..
01/07 ANTHERA PHARMACEUTICALS : Nasdaq stocks posting largest volume increases
01/07 ANTHERA PHARMACEUTICALS : Change in Directors or Principal Officers, Financial S..
01/07 ANTHERA PHARMACEUTICALS : Announces Appointment of Klara A. Dickinson as Senior ..
01/05 ANTHERA PHARMACEUTICALS : Nasdaq stocks posting largest volume increases
2014 ANTHERA PHARMACEUTICALS : Announces Lupus Symposium During 2015 JP Morgan Health..
More news
Sector news Biopharmaceuticals
07:08p JOHNSON & JOHNSON : Former FDA commissioner might testify against J&J in Philly ..
05:37pDJU.S. to Give $1 Billion to Fund Immunizations -- 2nd Update
05:31p ACTAVIS : Registration Statement for Pending Acquisition of Allergan Declared Ef..
Plus d'actualités du secteur Biopharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF